Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Courtney Miller-Chism

General Oncology · BCM

View

Dr. Michele Evans

General Oncology · NIH

View

Dr. Hannah Knochelmann

General Oncology

View

Dr. Don Dizon

General Oncology · Tufts Medicine

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    IADr. Ibrahim Azar

    Dr. Ibrahim Azar

    Hematology & Oncology · General Oncology
    Trinity Health Oakland Hospital
    ibrahim

    Research

    Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC.

    2025

    Via The Thoracic and Cardiovascular Surgeon Reports

    Research

    Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.

    2025

    Via JCO Oncology Advances

    Research

    Reno-Duodenal Fistula Caused by Metastatic Lung Cancer.

    2025

    Via Journal of Brown Hospital Medicine

    Research

    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

    2025

    Via Journal of Clinical Oncology

    Research

    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.

    2024

    Via Journal of Clinical Oncology

    Research

    Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.

    2024

    Via Journal of Clinical Oncology

    Research

    Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers.

    2023

    Via bioRxiv (Preprint)

    Research

    The Role of Surgery in Stage I Small Cell Lung Cancer: A National VA Database Analysis.

    2023

    Via Clinical Lung Cancer

    Research

    Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

    2023

    Via Molecular Cancer Therapeutics

    Research

    Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

    2023

    Via Clinical and Translational Medicine

    Research

    Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.

    2022

    Via Clinical Cancer Research

    Research

    Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.

    2022

    Via JAMA Network Open

    Research

    Preferences and Attitudes of Cardiologists in Management of Patients with Cancer.

    2022

    Via Palliative Medicine Reports

    Research

    The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.

    2021

    Via Cancer Medicine

    Research

    Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2-Mutation Positive Non-Small Cell Lung Cancer.

    2021

    Via Lung Cancer (Auckland)